SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Calypte Biomedical Corporation (CALY)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JanyBlueEyes who wrote (209)11/26/1997 4:31:00 PM
From: JanyBlueEyes  Read Replies (1) of 381
 
JAMA 11/17/97

Found this in the Journal of the American Medical Association
JAMA - Women's Health
Dated: 11/17/97

ama-assn.org

Increased Sensitivity to HIV-1 Antibody Detection
Nature Medicine (11/97) Vol. 3, No. 11, P. 1258; Urnovitz, Howard B.; Sturge,
Jerrilyn C.; Gottfried, Toby D.

Researchers from Calypte Biomedical in California report that accurate diagnosis of HIV-1 infection improves when tests of both blood products and urine are made.

A recent study, conducted in support of U.S. licensure of the Calypte HIV-1 urine enzyme immunassay (EIA), analyzed 11,344 paired urine and serum samples. Of the total, 10,163 had urine and serum either EIA non-reactive or western blot (WB) negative or indeterminate for HIV-1 antibodies, while 1,156 had serum and urine that was WB-positive.

The remaining 25 individuals were WB-positive in one but not the other. Of those, 10 had urine that was WB-confirmed positive and serum that was EIA non-reactive and WB negative or indeterminate; while 15 had serum that was WB-confirmed positive and urine that was EIA non-reactive or WB negative or indeterminate.

By pairing samples, diagnosis of HIV-1 infection increases in accuracy, the researchers said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext